» Articles » PMID: 39468082

Structural Variation of Types IV-A1- and IV-A3-mediated CRISPR Interference

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Oct 29
PMID 39468082
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR-Cas mediated DNA-interference typically relies on sequence-specific binding and nucleolytic degradation of foreign genetic material. Type IV-A CRISPR-Cas systems diverge from this general mechanism, using a nuclease-independent interference pathway to suppress gene expression for gene regulation and plasmid competition. To understand how the type IV-A system associated effector complex achieves this interference, we determine cryo-EM structures of two evolutionarily distinct type IV-A complexes (types IV-A1 and IV-A3) bound to cognate DNA-targets in the presence and absence of the type IV-A signature DinG effector helicase. The structures reveal how the effector complexes recognize the protospacer adjacent motif and target-strand DNA to form an R-loop structure. Additionally, we reveal differences between types IV-A1 and IV-A3 in DNA interactions and structural motifs that allow for in trans recruitment of DinG. Our study provides a detailed view of type IV-A mediated DNA-interference and presents a structural foundation for engineering type IV-A-based genome editing tools.

Citing Articles

Intricate interplay of CRISPR-Cas systems, anti-CRISPR proteins, and antimicrobial resistance genes in a globally successful multi-drug resistant Klebsiella pneumoniae clone.

Jiang J, Cienfuegos-Galletd A, Cienfuegos-Gallet A, Long T, Peirano G, Chu T Genome Med. 2025; 17(1):9.

PMID: 39885543 PMC: 11781037. DOI: 10.1186/s13073-025-01428-6.

References
1.
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S . CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007; 315(5819):1709-12. DOI: 10.1126/science.1138140. View

2.
Wang J, Pausch P, Doudna J . Structural biology of CRISPR-Cas immunity and genome editing enzymes. Nat Rev Microbiol. 2022; 20(11):641-656. DOI: 10.1038/s41579-022-00739-4. View

3.
Al-Shayeb B, Sachdeva R, Chen L, Ward F, Munk P, Devoto A . Clades of huge phages from across Earth's ecosystems. Nature. 2020; 578(7795):425-431. PMC: 7162821. DOI: 10.1038/s41586-020-2007-4. View

4.
Al-Shayeb B, Skopintsev P, Soczek K, Stahl E, Li Z, Groover E . Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors. Cell. 2022; 185(24):4574-4586.e16. DOI: 10.1016/j.cell.2022.10.020. View

5.
Moya-Beltran A, Makarova K, Acuna L, Wolf Y, Covarrubias P, Shmakov S . Evolution of Type IV CRISPR-Cas Systems: Insights from CRISPR Loci in Integrative Conjugative Elements of . CRISPR J. 2021; 4(5):656-672. PMC: 8658065. DOI: 10.1089/crispr.2021.0051. View